The president of commercial operations at Mission Pharmacal, Terrell (Terry) Herring also heads the company's sales services subsidiary, Alamo Pharma Services. Named one of the 100 most inspiring industry leaders by PharmaVOICE magazine in 2007 and 2008, and a "Red Jacket" honoree by the same publication in 2017, Terrell Herring also serves on the Advisory Board of BioAgilytix.

1. z
BioAgilytix Leads
Gene Therapy
Development
Terrell Herring

2. z
Introduction
 The president of commercial operations at Mission
Pharmacal, Terrell (Terry) Herring also heads the
company's sales services subsidiary, Alamo Pharma
Services. Named one of the 100 most inspiring
industry leaders by PharmaVOICE magazine in 2007
and 2008, and a "Red Jacket" honoree by the same
publication in 2017, Terrell Herring also serves on the
Advisory Board of BioAgilytix.
A bioanalytical lab supporting biotech and pharma
companies, BioAgilytix employs an international team
of professionals in the field of large molecule studies.
Among other areas, BioAgilytix places a strong
emphasis on the development of gene therapy.

3. z
BioAgilytix
 Gene therapy refers to the introduction of portions of
DNA into a patient's cells to prevent or treat disease.
This genetic material enters the cells via carriers
known as vectors, typically common viruses altered to
render them safe. Examples include the adeno-
associated virus (AAV) and the lentivirus.
BioAgilytix supports innovation in the field of gene
therapy through investment in the highest-quality
instrumentation to provide reliable neutralization and
sensitive delivery. The company also draws on
extensive experience with cell-based neutralizing
antibody assays and viral vectors.